ArticleThe Journal of antimicrobial chemotherapy2024
Penetration of isavuconazole into the epithelial lining fluid of patients with pulmonary fungal infections. Comment on: 'Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions'.
Alexis Maillard, Léo Froelicher Bournaud, Jean Pastre, Benjamin Planquette, Perrine Parize, Fanny Lanternier, Camille Rasmussen, Camille Chenevier-Gobeaux, Cherifa Cheurfa, Sihem Benaboud and 2 more
Abstract readLetterComment
In one paragraphArticle in The Journal of antimicrobial chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
12 authors.
Alexis MaillardParis Centre University Cochin Hospital, Infectious Diseases Stewardship Team, AP-HP, Paris, France.ORCID 0000-0002-7165-4103 Léo Froelicher BournaudClinical Pharmacology Department, Paris Centre University Cochin Hospital, AP-HP, Paris, France.
Jean PastreHôpital Européen Georges Pompidou, Service de Pneumologie et Soins Intensifs, AP-HP, Paris, France.
Benjamin PlanquetteHôpital Européen Georges Pompidou, Service de Pneumologie et Soins Intensifs, AP-HP, Paris, France.
Perrine ParizeDepartment of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, AP-HP, Paris, France.ORCID 0000-0002-0786-7518 Fanny LanternierDepartment of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, AP-HP, Paris, France.
Camille RasmussenParis Centre University Cochin Hospital, Infectious Diseases Stewardship Team, AP-HP, Paris, France.
Camille Chenevier-GobeauxParis Centre University Cochin Hospital, Biochemistry Laboratory, AP-HP, Paris, France.
Cherifa CheurfaIntensive Care Department, Paris Centre University Cochin Hospital, AP-HP, Paris, France.
Sihem BenaboudClinical Pharmacology Department, Paris Centre University Cochin Hospital, AP-HP, Paris, France.
Caroline CharlierParis Centre University Cochin Hospital, Infectious Diseases Stewardship Team, AP-HP, Paris, France.ORCID 0000-0002-9375-3620 Etienne CanouïParis Centre University Cochin Hospital, Infectious Diseases Stewardship Team, AP-HP, Paris, France.ORCID 0000-0003-0612-5691 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antifungal AgentsNitrilesPyridinesTriazolesHealthy VolunteersHumansInfusions, IntravenousLung Diseases, FungalAntifungal AgentsisavuconazoleNitrilesPyridinesTriazoles
What OpenQuestion holds
Textmetadata
Read underepoch 390